IRADIMED CORPORATION Schedules 2024 Annual Meeting of Stockholders

TL;DR

<b>Iradimed Corporation invites stockholders to its 2024 Annual Meeting on June 20, 2024, urging them to vote by proxy.</b>

AI Summary

IRADIMED CORP (IRMD) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Iradimed Corporation will hold its 2024 Annual Meeting of Stockholders on June 20, 2024, at 10:00 am local time. The meeting will take place at the company's offices located at 1025 Willa Springs Drive, Winter Springs, Florida 32708. Stockholders are encouraged to vote by proxy, either online, by telephone, or by mail, to ensure their shares are represented. The proxy statement provides detailed information on the matters to be voted upon at the meeting. Roger Susi, Chairman of the Board, President, and CEO, signed the letter to stockholders.

Why It Matters

For investors and stakeholders tracking IRADIMED CORP, this filing contains several important signals. This filing is a definitive proxy statement (DEF 14A) for the annual meeting, indicating the company is seeking shareholder votes on corporate matters. The meeting date and location are crucial for shareholders to exercise their voting rights and participate in corporate governance.

Risk Assessment

Risk Level: low — IRADIMED CORP shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks indicated.

Analyst Insight

Stockholders should review the proxy statement to understand the voting matters and cast their votes by the meeting date.

Key Numbers

• 2024 — Annual Meeting Year (2024 Annual Meeting of Stockholders)
• June 20 — Meeting Date (Annual Meeting to be held on Thursday, June 20, 2024)
• 10:00 am — Meeting Time (Annual Meeting at 10:00 am local time)

Key Players & Entities

• IRADIMED CORPORATION (company) — Registrant and Filer
• Roger Susi (person) — Chairman of the Board, President and Chief Executive Officer
• June 20, 2024 (date) — Date of Annual Meeting
• 10:00 am (time) — Time of Annual Meeting
• 1025 Willa Springs Drive, Winter Springs, Florida 32708 (location) — Location of Annual Meeting and Company Offices

FAQ

Industry Context

Iradimed Corporation operates in the medical device industry, specifically focusing on non-invasive monitoring technologies.

Regulatory Implications

This is a standard DEF 14A filing, a proxy statement required by the SEC for public companies holding annual shareholder meetings.

What Investors Should Do

1. Review the proxy statement for details on proposals and voting.
2. Vote your shares by proxy (online, phone, or mail) or in person at the meeting.
3. Note the meeting date and time: June 20, 2024, at 10:00 am local time.

Key Dates

• 2024-06-20: Annual Meeting of Stockholders — Shareholders will vote on corporate matters.

Year-Over-Year Comparison

This is the initial filing for the 2024 Annual Meeting proxy statement.

Key Financial Figures

• $0.0001 — ers of IRADIMED common stock, par value $0.0001 per share (" Common Stock "), at the cl

Filing Documents

• tmb-20240620xdef14a.htm (DEF 14A) — 555KB
• tmb-20240620xdef14a_a001.jpg (GRAPHIC) — 10KB
• tmb-20240620xdef14a_bg001.jpg (GRAPHIC) — 179KB
• tmb-20240620xdef14a_bg002.jpg (GRAPHIC) — 124KB
• 0001558370-24-006105.txt (&nbsp;) — 987KB

From the Filing

DEF 14A 1 tmb-20240620xdef14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a-12 IRADIMED CORPORATION (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. IRADIMED CORPORATION 1025 Willa Springs Drive, Winter Springs, FL 32708 April 29, 2024 Dear Stockholder: You are cordially invited to attend the 2024 Annual Meeting of Stockholders of IRADIMED CORPORATION, which will be held on Thursday, June 20, 2024, 10:00 am, local time, at 1025 Willa Springs Drive, Winter Springs, Florida 32708, the location of our offices (the "Annual Meeting"). The matters to be voted on at the Annual Meeting are listed in the accompanying notice of the Annual Meeting and are described in more detail in the accompanying Proxy Statement. Whether or not you plan to attend the Annual Meeting, we encourage you to vote either in person or by proxy. You may vote over the Internet as well as by telephone or by mail. When you have finished reading the proxy statement, you are urged to vote in accordance with the instructions set forth in this proxy statement. We encourage you to vote by proxy so that your shares will be represented and voted at the Annual Meeting, whether or not you can attend. We thank you for your continued support and we look forward to the Annual Meeting. Sincerely, /s/ Roger Susi Roger Susi Chairman of the Board, President and Chief Executive Officer IRADIMED CORPORATION 1025 Willa Springs Drive, Winter Springs, FL 32708 Notice of Annual Meeting of Stockholders to be held on Thursday, June 20, 2024 Notice is hereby given that the 2024 Annual Meeting of Stockholders (the "Annual Meeting") of IRADIMED CORPORATION (the "Company") will be held on Thursday, June 20, 2024, 10:00 am, local time, at 1025 Willa Springs Drive, Winter Springs, Florida 32708. The Annual Meeting is being held for the following purposes: 1. To elect the following persons to serve as directors until the 2025 annual meeting of stockholders and until his successor is duly elected and shall qualify, or until his earlier death, resignation, disqualification or removal : Roger Susi Monty Allen Anthony Vuoto Hilda Scharen-Guivel, and James Hawkins 2. To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024; and 3. To approve, on a non-binding advisory basis, the fiscal 2023 compensation of the Company's named executive officers. To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof. The accompanying proxy statement more fully describes these matters, and we urge you to read the information contained in the Proxy Statement carefully. The Company's Board of Directors recommends a vote "FOR" the director nominees listed in Proposal 1, and "FOR" Proposals 2 and 3. The Company's Board of Directors has fixed the close of business on April 22, 2024, as the record date for the determination of stockholders entitled to notice of, and to vote at, the Annual Meeting and any adjournments or postponement thereof. It is important that your shares be represented at the Annual Meeting regardless of the number of shares you hold. Whether or not you expect to attend the meeting in person, please complete, date, sign and return the accompanying proxy in the enclosed envelope to ensure the presence of a quorum at the meeting. If you have voted by proxy, and you attend the meeting, you may, if you prefer, revoke your proxy and vote your shares in person. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you will not be permitted to vote in person at the meeting unless you first obtain a legal proxy issued in your name from the record holder. By order of the Board of Directors, /s/ John Glenn John Glenn Corporate Secretary Winter Springs, Florida April 29, 2024 This Proxy Statement, dated April 29, 2024, is going to be first mailed to stockholders of IRADIMED CORPORATION on or about May 6, 2024. Important Notice Regarding Availability of Proxy Materials for Annual Meeting of Stockholders to be Held on Thursday, June 20, 2024, at 1025 Willa Springs

View Full Filing

View this DEF 14A filing on SEC EDGAR